Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
EpiCept Ceases Drug Discovery Operations, Cuts Workforce

January 12, 2009
EpiCept Corp. is discontinuing all drug discovery activities and reducing its workforce by approximately 65%. These actions are expected to reduce annual expenses by at least $5.5 million. EpiCept will direct its resources toward the registration of…  Read More »
XDx, BMS Enter Biomarker Pact

January 9, 2009
XDx, Inc. has signed a collaborative pharmacogenomics agreement with Bristol-Myers Squibb focused on identifying biomarkers for Systemic Lupus Erythematosus (SLE) for clinical diagnostic purposes associated with the development of BMS' rheumatoid art…  Read More »
Almac Clinical Technologies Expands Headquarters

January 9, 2009
Almac Clinical Technologies has added 6,000 sq. ft. of space at its Yardley, PA headquarters. The expansion is part of the company’s strategy to provide an environment that "spurs innovation, high quality project management, and customer s…  Read More »
GSK Resubmits Solzira NDA

January 9, 2009
GlaxoSmithKline and development partner XenoPort have resubmitted the NDA to the FDA requesting approval of Solzira Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).   The FDA requested that…  Read More »
Tekmira Gets $11.2M Commitment from Alnylam

January 8, 2009
Tekmira Pharmaceuticals expects to receive $11.2 million during the next three years from partner Alnylam Pharmaceuticals for process development and manufacturing services. This commitment is part of the company's manufacturing pact with Alnylam for…  Read More »
Crucell, Wyeth Discuss Acquisition

January 8, 2009
Crucell N.V. is in preliminary discussions with Wyeth for the purchase of the Dutch vaccine company in a transaction valued at nearly $1.4 billion. In a statement, Crucell confirmed the talks, saying it is in "friendly discussions with Wyeth tha…  Read More »
UPS To Manage Merck's U.S. Distribution

January 8, 2009
UPS has been selected by Merck to manage a significant portion of its U.S. distribution of pharmaceuticals and vaccines as well as to provide package transportation services. Through its subsidiary, UPS Supply Chain Solutions, UPS has assumed control…  Read More »
Keata Signs Consumer Supply Pact

January 7, 2009
Keata Pharma, a subsidiary of PharmEng International, has signed an agreement with an undisclosed global consumer healthcare company for the manufacture of branded non-prescription drug products for Canada and other international territories. This ne…  Read More »
Akrimax Enters Manufacturing Pact

January 7, 2009
Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009.       Akrimax president Alan L. Rubino…  Read More »
MDS Pharma Services

January 7, 2009
Rudy Howard has been named senior vice president and chief financial officer, MDSPS. Mr. Howard has experience as a senior financial executive in the pharmaceutical and CRO industry sectors, including six years as chief financial officer at Pharmaceu…  Read More »
Avéma Pharma Solutions

January 6, 2009
Thomas M. Salus has been appointed vice president, contract services, Avéma Pharma Solutions, a division of PL Developments, and Richard Thome has been named senior vice president, operations of both PL Developments and Avéma Pharma Sol…  Read More »
Galapagos Earns GSK Milestones

January 6, 2009
Galapagos NV has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline. Galapagos also reached milestones on other compounds in the alliance, earning milestone payments totaling $10.5 million. Under t…  Read More »
Valeant Pharmaceuticals

January 6, 2009
Rajiv De Silva has been appointed chief operating officer of Specialty Pharmaceuticals, Valeant Pharmaceuticals International, effective January 5, 2009. Mr. De Silva will be responsible for overseeing the U.S., Canadian and Australian specialty phar…  Read More »
PPD, Merck Enter Vax-Lab Pact

January 5, 2009
PPD, Inc. has purchased Merck’s 130,000-sq.-ft. vaccine testing lab and related equipment in Wayne, PA and hired the 80 Merck employees who operate the facility. PPD will provide assay development and immunogenicity testing services to support…  Read More »
DOR Gets SPA Clearance for orBec Trial

January 5, 2009
DOR BioPharma, Inc. has reached agreement with the FDA on the design of a confirmatory Phase III trial for its lead product orBec for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD). The agreement was made under the FDA's…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: